4.4 Article

Collectin-11/MASP Complex Formation Triggers Activation of the Lectin Complement Pathway - The Fifth Lectin Pathway Initiation Complex

期刊

JOURNAL OF INNATE IMMUNITY
卷 5, 期 3, 页码 242-250

出版社

KARGER
DOI: 10.1159/000345356

关键词

CL-K1; Collectin-11; Complement activation; Lectin pathway; MAP-1; MASP-1; MASP-2; MASP-3

资金

  1. Alfred Benzon Foundation
  2. Novo Nordisk Research Foundation
  3. Danish Cancer Society
  4. Svend Andersen Research Foundation
  5. Research Foundation of the Capital Region of Denmark
  6. Research Foundation of the Capital Region of Rigshospitalet
  7. Danish Medical Research Council

向作者/读者索取更多资源

Collectins and ficolins are important in the clearance of endogenous and exogenous danger materials. A new human collectin-11 was recently identified in low concentration in serum in complex with mannose-binding lectin (MBL)/ficolin-associated serine proteases. Collectin-11 binds to carbohydrate residues present on various microorganisms. Thus, we hypothesized that collectin-11 could be a novel initiation molecule in the lectin pathway of complement. We can show that collectin-11 associates with all the known MBL-associated serine proteases (MASP-1, MASP-2 and MASP-3) as well as the lectin complement pathway regulator MAP-1. Furthermore, we found that complex formation between recombinant collectin-11 and recombinant MASP-2 on Candida albicans leads to deposition of C4b. Native collectin-11 in serum mediated complement activation and deposition of C4b and C3b, and formation of the terminal complement complex on C. albicans. Moreover, spiking collectin-11-depleted serum, which did not mediate complement activation, with recombinant collectin-11 restored the complement activation capability. These results define collectin-11 as the fifth recognition molecule in the lectin complement pathway in addition to MBL, ficolin-1, ficolin-2 and ficolin-3. Copyright (C) 2012 S. Karger AG, Basel

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据